PRECISION BIOSCIENCES INC
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.3M | $68.7M | $48.7M | $25.1M | $115.5M | $24.3M | $1.07B | $10.9M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $54.2M | $59.6M | $53.4M | $46.1M | $115.2M | $98.1M | $82.4M | $45.1M |
| SG&A Expense | $32.2M | $35.3M | $39.1M | $41.3M | $39.7M | $36.1M | $27.0M | $13.7M |
| Operating Income | $-52.1M | $-26.2M | $-43.7M | $-62.3M | $-39.4M | $-109.8M | $-87.2M | $-47.9M |
| Operating Margin | -152.2% | -38.1% | -89.8% | -248.3% | -34.1% | -452.2% | -8.1% | -440.2% |
| Interest Expense | — | $1.8M | $2.2M | $1.1M | $132.0K | — | $182.0K | — |
| Pretax Income | $-45.7M | $7.2M | — | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | — | — | — | $23.0K | — | — |
| Net Income | $-45.7M | $7.2M | $-61.3M | $-111.6M | $-30.6M | $-109.0M | $-92.9M | $-46.0M |
| Net Margin | -133.4% | 10.4% | -125.8% | -444.8% | -26.5% | -448.9% | -8.7% | -423.0% |
| EPS (Basic) | $-3.56 | $1.05 | $-15.96 | $-38.10 | $-0.52 | $-2.09 | $-2.21 | $-2.92 |
| EPS (Diluted) | $-3.56 | $1.04 | $-15.96 | $-38.10 | $-0.52 | $-2.09 | $-2.21 | $-2.92 |
| Shares Outstanding (Basic) | 12.8M | 6.8M | 3.8M | 2.9M | 58.7M | 52.7M | 51.2M | 15.9M |
| Shares Outstanding (Diluted) | 12.8M | 6.9M | 3.8M | 2.9M | 58.7M | 52.7M | 51.2M | 15.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |